Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.
Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela.
Company Financials
Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
---|---|---|---|---|
31-Mar-20 | 638.92 | 500.71 | -79.63 | -300.03 |
31-Mar-21 | 1144.41 | 978.13 | 63.23 | -47.07 |
31-Mar-22 | 1385.98 | 2237.14 | 227.32 | 480.25 |
Amount in ₹ Lakhs |
Objects of the Issue
The Issue Proceeds from the Fresh Issue will be utilized for the following objects:
1. To Meet Working Capital Requirements
2. Product registration in the international markets
3. General Corporate Purpose
4. To meet Public Issue Expenses
Trident Lifeline IPO Details
Trident Lifeline IPO Date | Sep 26, 2022 to Sep 29, 2022 |
Trident Lifeline IPO Face Value | ₹10 per share |
Trident Lifeline IPO Price | ₹101 per share |
Trident Lifeline IPO Lot Size | 1200 Shares |
Issue Size | 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr) |
Fresh Issue | 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
NII (HNI) Shares Offered | 50% of the net offer |
Retail Shares Offered | 50% of the net offer |
Company Promoters | Mr. Hardik Jigishkumar Desai, Mr. Mayurkumar Mansukhbhai Gajera, Mrs. Rupaben C Jariwala, Mrs. Rinkal Mayurbhai Gajera, Mr. Tarang Nathabhai Gajera and Mr. Mohak Nathabhai Gajera are the company promoters. |
Trident Lifeline IPO Timeline
Trident Lifeline IPO opens on Sep 26, 2022, and closes on Sep 29, 2022. The Trident Lifeline IPO bid date is from Sep 26, 2022 10.00 A.M. to Sep 29, 2022 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.
Event | Date |
---|---|
Trident Lifeline IPO Opening Date | Sep 26, 2022 |
Trident Lifeline IPO Closing Date | Sep 29, 2022 |
Basis of Allotment | Oct 4, 2022 |
Initiation of Refunds | Oct 6, 2022 |
Credit of Shares to Demat | Oct 7, 2022 |
Trident Lifeline IPO Listing Date | Oct 10, 2022 |
Trident Lifeline IPO Lot Size
The Trident Lifeline IPO lot size is 1200 shares. A retail-individual investor can apply for up to 1 lots (1200 shares or ₹121,200).
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1200 | ₹121,200 |
Retail (Max) | 1 | 1200 | ₹121,200 |
Trident Lifeline IPO Promoter Holding
Pre Issue Share Holding | 100% |
Post Issue Share Holding | 69.57% |
Trident Lifeline IPO Review
TLL is operating in a highly competitive segment with third-party contract manufacturing. Based on FY22 earnings, the issue is aggressively priced. There is no harm in skipping this pricy issue. Read detail review…
Trident Lifeline IPO Prospectus
Company Contact Information
Trident Lifeline Limited
2nd Floor, Shop-2004,
North Extension, Falsawadi Begumpura, Nodh-4/1650,
Sahara Darwaja, Surat – 395003
Phone: 8160276395
Email: compliance@tridentlifeline.com
Website: http://www.tridentlifeline.com/
Trident Lifeline IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: trilife.ipo@linkintime.co.in
Website: https://linkintime.co.in/